Press Releases

Date Title and Summary
Toggle Summary Accuray Incorporated Reports Inducement Awards Under NASDAQ Listing Rules
SUNNYVALE, Calif. , Nov. 6, 2019 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Stock Market Rules, equity inducement awards to Suzanne Winter , the company's new Senior Vice President, Chief Commercial Officer.  As a material inducement to Ms.
Toggle Summary Accuray Reports Fiscal 2020 First Quarter Financial Results
SUNNYVALE, Calif. , Oct. 29, 2019 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the first quarter of fiscal 2020 ended September 30, 2019 . Recent Company Highlights Gross orders increased 28 percent year over year to $78.5 million 11 orders received
Toggle Summary First Asia-Pacific hospital treats patients with RayStation and Radixact
SUNNYVALE, Calif. , Oct. 28, 2019 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) – Thailand's Lopburi Cancer Hospital , a center of excellence for cancer treatment, is the first in the Asia-Pacific region to clinically use the combination of RaySearch's treatment planning system RayStation®
Toggle Summary Accuray Appoints Medtech Veteran Suzanne Winter as Chief Commercial Officer
SUNNYVALE, Calif. , Oct. 21, 2019 /PRNewswire/ --  Accuray Incorporated (Nasdaq: ARAY) announced today that Suzanne Winter has joined the company as Senior Vice President, Chief Commercial Officer effective October 21, 2019 . Ms. Winter will have global responsibility for the commercial function
Toggle Summary Accuray To Report Fiscal 2020 First Quarter Financial Results on October 29, 2019
  SUNNYVALE, Calif. , Oct. 10, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its first quarter ended September 30, 2019 on Tuesday, October 29, 2019 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT / 4:30 p.m.
Toggle Summary Accuray Educates Radiation Oncology Practices on the Potential Impact of the Proposed Alternative Payment Model (RO-APM)
SUNNYVALE, Calif. , Sept. 19, 2019 /PRNewswire/ --  Accuray Incorporated  (NASDAQ: ARAY) today published an informational guide designed to help radiation oncology practices understand the complexities of the much-anticipated proposed Medicare & Medicaid reimbursement changes.
Toggle Summary Data Published in The Lancet Oncology Suggest CyberKnife® Prostate Patients Experienced Lower Levels of Acute Genitourinary Toxicity (Grade 2 or Higher) Than Patients Treated on a Conventional Linear Accelerator
SUNNYVALE, Calif. , Sept. 17, 2019 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announces that The Lancet Oncology , a high impact and leading global peer-reviewed oncology journal, has published patient- and clinician-reported outcomes data from the PACE — Prostate Advances in Comparative
Toggle Summary China Announces Tariff Exclusion for Medical Linear Accelerators
SUNNYVALE, Calif. , Sept. 16, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced that, on September 11, 2019 , China's Customs Tariff Commission of the State Council issued a tariff exemption for medical linear accelerators.  The tariff exemption, which will be effective September
Toggle Summary Accuray Appoints Healthcare Veteran James M. Hindman to Board of Directors
SUNNYVALE, Calif. , Sept. 12, 2019 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) strengthened its Board of Directors with the appointment of James (Jim) M. Hindman , effective as of September 6, 2019 , and expanding the company's Board to nine members. Mr.
Toggle Summary Geisinger Medical Center is First in Pennsylvania to Treat Cancer Patients with Accuray Radixact® System
Leading Health Services Organization Hospital Selected the New Radiation Therapy Device to Expand Its Clinical Capabilities and Provide Treatment Options for a Wider Range of Patients SUNNYVALE, Calif. , Sept. 10, 2019 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that the